Mark E Deffebach
Overview
Explore the profile of Mark E Deffebach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hedstrom G, Hooker E, Howard M, Shull S, Golden S, Deffebach M, et al.
Ann Am Thorac Soc
. 2022 Feb;
19(8):1379-1389.
PMID: 35167780
Millions of people are diagnosed with incidental pulmonary nodules every year. Although most nodules are benign, it is universally recommended that all patients be assessed to determine appropriate follow-up and...
2.
Nugent S, Golden S, Hooker E, Sullivan D, Thomas Jr C, Deffebach M, et al.
Ann Am Thorac Soc
. 2020 May;
17(8):988-997.
PMID: 32433897
Because of improvements in screening, there is an increasing number of patients with early-stage non-small-cell lung cancer (NSCLC) who are making treatment decisions. Among patients with suspected stage I NSCLC,...
3.
Atkins K, Chen Y, Elliott D, Doshi T, Ognjenovic S, Vachhani A, et al.
J Radiosurg SBRT
. 2018 Jan;
3(3):203-213.
PMID: 29296403
Purpose: Narrow PTV margins and steep dose gradients underscore the importance of evaluating breathing-associated tumor motion for lung SBRT. The specific aim of this study was to determine the impact...
4.
Nugent S, Golden S, Thomas Jr C, Deffebach M, Sukumar M, Schipper P, et al.
Support Care Cancer
. 2017 Dec;
26(5):1625-1633.
PMID: 29209835
Purpose: Limited data exist about patient-centered communication (PCC) and patient-centered outcomes among patients who undergo surgery or stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC)....
5.
Golden S, Thomas Jr C, Deffebach M, Sukumar M, Schipper P, Tieu B, et al.
BMC Res Notes
. 2017 Dec;
10(1):642.
PMID: 29187237
Objective: While surgical resection is recommended for most patients with early stage lung cancer, stereotactic body radiotherapy (SBRT) is being increasingly utilized. Provider-patient communication regarding risks/benefits of each approach may...
6.
Golden S, Thomas Jr C, Deffebach M, Sukumar M, Schipper P, Tieu B, et al.
Ann Am Thorac Soc
. 2016 May;
13(8):1361-9.
PMID: 27182889
Rationale: While surgical resection is recommended for most patients with early stage lung cancer according to the National Comprehensive Cancer Network guidelines, stereotactic body radiotherapy is increasingly being used. Provider-patient...
7.
Moseson E, Wiener R, Golden S, Au D, Gorman J, Laing A, et al.
Ann Am Thorac Soc
. 2016 May;
13(5):651-9.
PMID: 27144794
Rationale: Many patients are diagnosed with small pulmonary nodules for which professional societies recommend subsequent imaging surveillance. Adherence to these guidelines involves many steps from both clinicians and patients but...
8.
Deffebach M, Humphrey L
Surg Clin North Am
. 2015 Aug;
95(5):967-78.
PMID: 26315517
Screening for lung cancer in high-risk individuals with annual low-dose computed tomography has been shown to reduce lung cancer mortality by 20% and is recommended by multiple health care organizations....
9.
10.
Slatore C, Gould M, Au D, Deffebach M, White E
BMC Cancer
. 2011 Jun;
11:228.
PMID: 21649915
Background: Lung cancer is the leading cause of cancer death in the United States. Identifying factors associated with stage of diagnosis can improve our understanding of biologic and behavioral pathways...